Why become a Fellow in ACCP?
Fellowship is the highest category of membership granted by ACCP and, as such, is awarded to those with exemplary credentials and dedication to the betterment of the discipline and provides an opportunity to shape the future of clinical pharmacology. Becoming a Fellow in ACCP is a recognition by your peers of an experience level or a milestone in professional achievement that provides opportunities to participate and contribute to the society at a higher level. Being a Fellow provides a sense of community and collegiality and it acknowledges that you are part of a respected scientific society where one can exchange scientific knowledge. Those who are Fellows effectively serve as Ambassadors of the society to the greater clinical pharmacology community. The FCP acronym implies a certain prestige and pride in the greater clinical pharmacology community and opens doors to talk about ACCP and clinical pharmacology to those who are interested. Fellows are frequently selected to chair committees and may be elected to serve on the Board of Regents or as an Officer that governs the society.
How to apply for Fellow
Fellow will be considered for any applicant that meets the requirements as
specified below. ACCP Members wishing to become a Fellow must begin by logging
in and updating their profile on the ACCP website. In addition, they must send a current CV and
two Letters of Support from current ACCP Fellows to [email protected]. Applications require the approval of the Board of
Regents and must be submitted no later than 45 days prior to the next Board of
Regents Meeting, as noted below.
Fellows who wish to reinstate membership after failure to pay dues for a period of three (3) years or more shall be required to reinstate as a Member and reapply for Fellow in the credentials period following approval as a Reinstated Member. The application for Fellow must include all requirements for Fellowship as noted below. Any questions may be address to [email protected].
Requirements for Fellowship are as follows: